Development and Validation of a Model Predicting Malignant Potential of Adnexal Masses in Areas with Scarcity of Ultrasound Resources.

IF 2.5 3区 医学 Q3 ONCOLOGY Oncology Pub Date : 2024-12-23 DOI:10.1159/000542952
Guangxia Cui, Yu Guo, Wenpei Bai
{"title":"Development and Validation of a Model Predicting Malignant Potential of Adnexal Masses in Areas with Scarcity of Ultrasound Resources.","authors":"Guangxia Cui, Yu Guo, Wenpei Bai","doi":"10.1159/000542952","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Appropriately stratifying the risk of adnexal masses is of great importance. Many diagnostic algorithms have been devised, most of which rely on ultrasound features. However, some remote areas lack trained sonographers. This study aimed to develop an alternative model to distinguish between malignant and benign adnexal masses in resource-constrained settings using clinical information rather than ultrasound data.</p><p><strong>Methods: </strong>The study included women diagnosed with an adnexal tumor and scheduled for surgery between 2020 and 2023. Participants were divided into two groups based on histopathology reports: those with malignant adnexal masses and those with benign ones. Univariate and multivariate logistic regression analyses were used to identify independent predictors of adnexal mass malignancy. The training set yielded a nomogram model, which was then validated in the validation set. The model's effectiveness was evaluated using receiver operating characteristic (ROC), calibration, and clinical decision curve analysis (DCA) curves.</p><p><strong>Results: </strong>We randomly assigned 550 participants to the training and the validation sets in an 8:2 ratio. Logistic regression analyses identified age (OR = 1.044, p = 0.003), abdominal distension (OR = 0.139, p < 0.001), serum CA125 (OR = 1.007, p < 0.001), and serum carcinoembryonic antigen (CEA) (OR = 1.291, p = 0.004) as independent risk factors for predicting malignant adnexal tumors. A nomogram was constructed using these factors. The ROC curve showed an area under the curve of 0.846 (95% confidence interval [CI]: 0.783, 0.908) in the training set and 0.817 (95% CI: 0.668, 0.966) in the validation set. The calibration curve showed good consistency between model predictions and actual outcomes. The DCA curve demonstrated a considerable clinical advantage afforded by the model.</p><p><strong>Conclusion: </strong>The logistic regression model can aid gynecologists - particularly those in areas with limited access to skilled sonographers - in identifying patients at high risk and implementing appropriate management strategies.</p>","PeriodicalId":19497,"journal":{"name":"Oncology","volume":" ","pages":"1-10"},"PeriodicalIF":2.5000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542952","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Appropriately stratifying the risk of adnexal masses is of great importance. Many diagnostic algorithms have been devised, most of which rely on ultrasound features. However, some remote areas lack trained sonographers. This study aimed to develop an alternative model to distinguish between malignant and benign adnexal masses in resource-constrained settings using clinical information rather than ultrasound data.

Methods: The study included women diagnosed with an adnexal tumor and scheduled for surgery between 2020 and 2023. Participants were divided into two groups based on histopathology reports: those with malignant adnexal masses and those with benign ones. Univariate and multivariate logistic regression analyses were used to identify independent predictors of adnexal mass malignancy. The training set yielded a nomogram model, which was then validated in the validation set. The model's effectiveness was evaluated using receiver operating characteristic (ROC), calibration, and clinical decision curve analysis (DCA) curves.

Results: We randomly assigned 550 participants to the training and the validation sets in an 8:2 ratio. Logistic regression analyses identified age (OR = 1.044, p = 0.003), abdominal distension (OR = 0.139, p < 0.001), serum CA125 (OR = 1.007, p < 0.001), and serum carcinoembryonic antigen (CEA) (OR = 1.291, p = 0.004) as independent risk factors for predicting malignant adnexal tumors. A nomogram was constructed using these factors. The ROC curve showed an area under the curve of 0.846 (95% confidence interval [CI]: 0.783, 0.908) in the training set and 0.817 (95% CI: 0.668, 0.966) in the validation set. The calibration curve showed good consistency between model predictions and actual outcomes. The DCA curve demonstrated a considerable clinical advantage afforded by the model.

Conclusion: The logistic regression model can aid gynecologists - particularly those in areas with limited access to skilled sonographers - in identifying patients at high risk and implementing appropriate management strategies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
超声资源缺乏地区附件肿块恶性潜能预测模型的建立与验证。
对附件肿块的危险性进行适当的分级是非常重要的。许多诊断算法已经被设计出来,其中大多数依赖于超声特征。然而,一些偏远地区缺乏训练有素的超声技师。本研究旨在开发一个替代模型,以区分恶性和良性附件肿块在资源有限的设置使用临床信息,而不是超声数据。方法:该研究纳入了诊断为附件肿瘤并计划在2020年至2023年之间进行手术的女性。参与者根据组织病理学报告分为两组:恶性附件肿块组和良性附件肿块组。单因素和多因素logistic回归分析用于确定附件肿块恶性的独立预测因素。训练集产生了一个模态图模型,然后在验证集中进行验证。采用受试者工作特征(ROC)、校准曲线和临床决策分析(DCA)曲线评估模型的有效性。结果:我们以8:2的比例随机分配了550名参与者到训练组和验证组。Logistic回归分析发现,年龄(OR = 1.044, P = 0.003)、腹胀(OR = 0.139, P < 0.001)、血清CA125 (OR = 1.007, P < 0.001)、血清癌胚抗原(CEA) (OR = 1.291, P = 0.004)是预测附件恶性肿瘤的独立危险因素。利用这些因素构造了一个模态图。ROC曲线显示,训练集的曲线下面积(AUC)为0.846(95%可信区间[CI]: 0.783, 0.908),验证集的曲线下面积(AUC)为0.817 (95% CI: 0.668, 0.966)。校正曲线在模型预测和实际结果之间具有良好的一致性。DCA曲线显示了该模型提供的相当大的临床优势。结论:逻辑回归模型可以帮助妇科医生,特别是在那些无法获得熟练超声检查的地区,识别高风险患者并实施适当的管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Oncology
Oncology 医学-肿瘤学
CiteScore
6.00
自引率
2.90%
发文量
76
审稿时长
6-12 weeks
期刊介绍: Although laboratory and clinical cancer research need to be closely linked, observations at the basic level often remain removed from medical applications. This journal works to accelerate the translation of experimental results into the clinic, and back again into the laboratory for further investigation. The fundamental purpose of this effort is to advance clinically-relevant knowledge of cancer, and improve the outcome of prevention, diagnosis and treatment of malignant disease. The journal publishes significant clinical studies from cancer programs around the world, along with important translational laboratory findings, mini-reviews (invited and submitted) and in-depth discussions of evolving and controversial topics in the oncology arena. A unique feature of the journal is a new section which focuses on rapid peer-review and subsequent publication of short reports of phase 1 and phase 2 clinical cancer trials, with a goal of insuring that high-quality clinical cancer research quickly enters the public domain, regardless of the trial’s ultimate conclusions regarding efficacy or toxicity.
期刊最新文献
High expression of tetraspanin CD63 predicts poor prognosis in esophageal squamous cell carcinoma. Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective Study. Constructing and Validating Models for Predicting Gleason Grade Group Upgrading Following Radical Prostatectomy in Localized Prostate Cancer: A Comparison between Machine Learning Algorithms and Conventional Logistic Regression. Post-Marketing Safety of Temozolomide: A Pharmacovigilance Study Based on the Food and Drug Administration Adverse Event Reporting System. Health-Related Quality of Life in a Real-World Cohort of Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1